Sarepta Therapeutics, Inc. current ratio

The Current Ratio as of November 2026 (TTM) for Sarepta Therapeutics, Inc. (SRPT) is 4.42

According to Sarepta Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.42. This represents a change of 23.51% compared to the average of 3.58 of the last 4 quarters.

Sarepta Therapeutics, Inc. (SRPT) Historical Current Ratio (quarterly & annually)

How has SRPT Current Ratio performed in the past?

The mean historical Current Ratio of Sarepta Therapeutics, Inc. over the last ten years is 5.89. The current 4.42 Current Ratio has changed -24.97% with respect to the historical average. Over the past ten years (40 quarters), SRPT's Current Ratio was at its highest in in the December 2017 quarter at 13.91. The Current Ratio was at its lowest in in the December 2025 quarter at 2.32.

Sarepta Therapeutics, Inc. (SRPT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sarepta Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sarepta Therapeutics, Inc. (SRPT) Average Current Ratio

How has SRPT Current Ratio performed in the past?

The current Current Ratio of Sarepta Therapeutics, Inc. (SRPT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Sarepta Therapeutics, Inc. (SRPT) Current Ratio vs. Peers

How is SRPT’s Current Ratio compared to its peers?

Sarepta Therapeutics, Inc.’s Current Ratio is less than Capricor Therapeutics, Inc. (7.35), less than Solid Biosciences Inc. (13.82), less than PepGen Inc. (13.36), greater than PTC Therapeutics, Inc. (3.27), less than Ionis Pharmaceuticals, Inc. (7.88), less than Dyne Therapeutics, Inc. (12.02), less than Wave Life Sciences Ltd. (8.38), greater than Alnylam Pharmaceuticals, Inc. (2.48), less than Design Therapeutics, Inc. (18.86), less than Intellia Therapeutics, Inc. (6.65),

Build a custom stock screener for Sarepta Therapeutics, Inc. (SRPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sarepta Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sarepta Therapeutics, Inc. (SRPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sarepta Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.